Obesity Drug Race Intensifies Between Novo Nordisk and Eli Lilly

The competition in the obesity drug market is heating up as pharmaceutical giants Novo Nordisk and Eli Lilly vie for market dominance, with Novo Nordisk making strides to catch up.

3 Aug, 05:02 — 3 Aug, 05:02

Post Share

Sources

Showing 1 of 1 sources

ReutersVery High24d ago

Obesity battle heats up again as Novo claws way back into race with Lilly - Reuters

Obesity battle heats up again as Novo claws way back into race with Lilly Reuters

Read full article →

PERSPECTA

PERSPECTA

Obesity Drug Race Intensifies Between Novo Nordisk and Eli Lilly

Sources

Obesity battle heats up again as Novo claws way back into race with Lilly - Reuters

Related Stories

Nvidia Reports Strong Earnings Driven by Surging AI Demand

Canada Removes U.S. Seafood From Retaliatory Tariff List Amid Trade Tensions

Nvidia Launches Employee-Funded PAC Amid Massive Memory Chip Expansion

TotalEnergies Completes Exit From Sanctioned Russian LNG Project

PERSPECTA